Increased probability of expression from modified retroviral vectors in embryonal stem cells and embryonal carcinoma cells

Journal of Virology

Volumn 71, Issue 12, 1997, Pages 9466-9474

  Robbins, Paul B ^a   Yu, Xiao Jin ^a   Skelton, Dianne M ^a   Pepper, Karen A ^a   Wasserman, Richard M ^a   Zhu, Li ^a   Kohn, Donald B ^a  

^a Mail Stop No 62 ^*

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; NERVE GROWTH FACTOR; VIRUS VECTOR;

ARTICLE; BINDING SITE; CARCINOMA CELL; ENHANCER REGION; ENZYME ASSAY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTER; GENE EXPRESSION; LONG TERMINAL REPEAT; MURINE LEUKEMIA VIRUS; NORTHERN BLOTTING; PRIORITY JOURNAL; PROBABILITY; PROMOTER REGION; QUANTITATIVE DIAGNOSIS; REPORTER GENE; REPRESSOR GENE; RETROVIRUS;

EID: 0030862341     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.12.9466-9474.1997     Document Type: Article

References (53)

1. Agrawal, Y. P., R. S. Agrawal, A. M. Sinclair, D. Young, M. Maruyama, F. Levine, and A. D. Ho. 1996. Cell-cycle kinetics and VSV-G pseudotyped retrovirus-mediated gene transfer in blood-derived CD34+ cells. Exp. Hematol. 24:738-747.
2. Barklis, E., R. Mulligan, and R. Jaenisch. 1986. Chromosomal position or virus mutation permits retrovirus expression in embryonal carcinoma cells. Cell 47:391-399.
3. Becker, K. G., P. Jedlicka, N. S. Templeton, L. Liotta, and K. Ozato. 1994. Characterization of hUCRBP (YY1,NF-E1, δ): a transcription factor that binds to the regulatory regions of many viral and cellular genes. Gene 150:259-266.
4. Bowtell, D. D. L., S. Cory, G. R. Johnson, and T. J. Gonda. 1988. Comparison of expression in hemopoietic cells by retroviral vectors carrying two genes. J. Virol. 62:2464-2473.
5. Boyes, J., and A. Bird. 1991. DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein. Cell 64:1123-1134.
6. Brandeis, M., D. Frank, I. Keshet, Z. Siegfried, M. Mendelsohn, A. Nemes, V. Temper, A. Razin, and H. Cedar. 1994. Sp1 elements protect a CpG island from de novo methylation. Nature (London) 371:435-438.
7. Byun, J., J. M. Kim, S. Yu, P. D. Robbins, J. Yim, and S. Kim. 1996. Analysis of the relative level of gene expression from different retroviral vectors used for gene therapy. Gene Ther. 3:780-788.
8. Cedar, H. 1988. DNA methylation and gene activity: minireview. Cell 53:3-4.
9. Challita, P.-M., and D. B. Kohn. 1994. Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc. Natl. Acad. Sci. USA 91:2567-2571.
10. Challita, P.-M., D. Skelton, A. El-Khoueiry, X.-J. Yu, K. Weinberg, and D. B. Kohn. 1995. Multiple modifications in cis elements of the long terminal repeat of retroviral vectors lead to increased expression and decreased DNA methylation in embryonic carcinoma cells. J. Virol. 69:748-755.
11. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
12. Colicelli, J., and S. P. Goff. 1987. Isolation of a recombinant murine leukemia virus utilizing a new primer tRNA. J. Virol. 57:37-45.
13. Ellis, J., X. Wu, and P. Pasceri. 1996. Evaluation of β-globin gene therapy vectors in single copy transgenic mice. Presented at the Cold Spring Harbor Conference on Gene Therapy, Cold Spring Harbor, N.Y.
14. Evans, M. J., and M. H. Kaufman. 1981. Establishment in culture of pluripotent cells from mouse embryos. Nature 292:154-156.
15. Feuer, G., M. Taketo, R. C. Hanecak, and H. Fan. 1989. Two blocks in Moloney murine leukemia virus expression in undifferentiated F9 embryonal carcinoma cells as determined by transient expression assays. J. Virol. 63: 2317-2324.
16. Flanagan, J. R., K. G. Becker, D. L. Ennist, S. L. Gleason, P. H. Daggers, B.-Z. Levi, E. Appella, and K. Ozato. 1992. Cloning of a transcription factor that binds to the upstream conserved region of Moloney murine leukemia virus. Mol. Cell. Biol. 12:38-44.
17. Flanagan, J. R., A. M. Krieg, E. E. Max, and A. S. Khan. 1989. Negative control region at the 5′ end of murine leukemia virus long terminal repeat. Mol. Cell. Biol. 9:739-746.
18. Franz, T., F. Hilberg, B. Seliger, C. Stocking, and W. Ostertag. 1986. Retroviral mutants efficiently expressed in embryonal carcinoma cells. Proc. Natl. Acad. Sci. USA 83:3292-3296.
19. Gorman, C. M., P. W. J. Rigby, and D. P. Lane. 1985. Negative regulation of viral enhancers in undifferentiated embryonic stem cells. Cell 42:519-526.
20. Grez, M., E. Akgun, F. Hilberg, and W. Ostertag. 1990. Embryonic stem cell virus, a recombinant murine retrovirus with expression in embryonic stem cells Proc. Natl. Acad. Sci. USA 87:9202-9206.
21. Grez, M., M. Zornig, J. Nowock, and M. Ziegler. 1991. A single point mutation activates the Moloney murine leukemia virus long terminal repeat in embryonal stem cells. J. Virol. 65:4691-4698.
22. Hilberg, F., C. Stocking, W. Ostertag, and M. Grez. 1987. Functional analysis of a retroviral host-range mutant: altered long terminal repeat sequences allow expression in embryonal carcinoma cells. Proc. Natl. Acad. Sci. USA 84:5232-5236.
23. Hoeben, R. C., A. A. J. Mighielsen, R. C. M. van der Jagt, H. van Ormondt, and A. J. van der Eb. 1991. Inactivation of the Moloney murine leukemia virus long terminal repeat in murine fibroblast cell lines is associated with methylation and dependent on its chromosomal position. J. Virol. 65:904-912.
24. Kempler, G., B. Freitag, B. Berwin, O. Nanassy, and E. Barklis. 1993. Characterization of the Moloney murine leukemia virus stem cell-specific repressor binding site. Virology 193:590-599.
25. Kohn, D. B. 1995. The current status of gene therapy using hematopoietic stem cells. Curr. Opin. Pediatr. 7:56-63.
26. Kollek, R., C. Stocking, F. Smadja-Joffe, and W. Ostertag. 1984. Molecular cloning and characterization of a leukemia-inducing myeloproliferatrve sarcoma virus and two of its temperature sensitive mutants. J. Virol. 50:717-724.
27. Lengauer, C., K. W. Kinzler, and B. Vogelstein. 1997. DNA methylation and genetic instability in colorectal cancer cells. Proc. Natl. Acad. Sci. USA 94:2545-2550.
28. Linney, E., B. Davis, J. Overhauser, E. Chao, and H. Fan. 1984. Non-function of a Moloney murine leukemia virus regulatory sequence in F9 embryonal carcinoma cells. Nature 308:470-472.
29. Loh, T. P., L. L. Sievert, and R. W. Scott. 1987. Proviral sequences that restrict retroviral expression. Mol. Cell. Biol. 7:3775-3784.
30. Lund, A. H., M. Duch, and F. S. Pedersen. 1996. Transcriptional silencing of retroviral vectors. J. Biomed. Sci. 3:365-378.
31. Macleod, D., J. Charlton, J. Mullins, and A. P. Bird. 1994. Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island. Genes Dev. 8:2282-2292.
32. Malik, P., S. A. McQuiston, X.-J. Yu, K. A. Pepper, W. J. Krall, G. M. Podsakoff, G. J. Kurtzman, and D. B. Kohn. 1997. Recombinant adeno-associated virus mediates a high level of gene transfer but less efficient integration in the K562 human hematopoietic cell line. J. Virol. 71:1284-1296.
33. Markowitz, D., S. Goff, and A. Bank. 1988. A safe packaging line for gene transfer: separating viral genes on two different plasmids. J. Virol. 62:1120-1124.
34. McCune, S. L., and T. M. Townes. 1994. Retroviral vector sequences inhibit human β-globin gene expression in transgenic mice. Nucleic Acids Res. 22:4477-4481.
35. Miller, A. D. 1996. Cell-surface receptors for retroviruses and implications for gene transfer. Proc. Natl. Acad. Sci. USA 93:11407-11413.
36. Miller, A. D., and G. J. Rosman. 1989. Improved retroviral vectors for gene transfer and expression. BioTechniques. 7:980-990.
37. Miller, A. D., and C. Buttimore. 1986. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol. 6:2895-2902.
38. Milot, E., P. Fraser, and F. Grosfeld. 1996. Position effects and genetic disease. Trends Genet. 12:123-126.
39. Neumann, J. R., C. A. Morency, and K. O. Russian. 1987. A novel rapid assay for chloramphenicol acetyltransferase gene expression. BioTechniques. 5: 444-447.
40. Niwa, O., Y. Yokota, H. Ishida, and T. Sugahara. 1983. Independent mechanisms involved in suppression of Moloney murine leukemia virus genome during differentiation of murine teratocarcinoma cells. Cell 32:1105-1113.
41. Ostertag, W., K. Vehemeyer, B. Fagg, I. B. Pragnell, W. Paetz, M. C. Le Bousse, F. Smadja-Joffe, B. Klein, C. Jasmin, and H. Eisen. 1980 Myelo-proliferative virus, a cloned murine sarcoma virus with spleen focus-forming properties in adult mice. J. Virol. 33:573-582.
42. Petersen, R., G. Kempler, and E. Barklis. 1991. A stem cell-specific silencer in the primer-binding site of a retrovirus. Mol. Cell. Biol. 11:1214-1221.
43. Prince, V. E., and P. W. J. Rigby. 1991. Derivatives of Moloney murine sarcoma virus capable of being transcribed in embryonal carcinoma stem cells have gained a functional Sp1 site. J. Virol. 65:1803-1811.
44. Rhazin A., and H. Cedar. 1993. DNA methylation and embryogenesis, p. 343-357. In J. P. Jost and H. P. Saluz (ed.), DNA methylation: molecular biology and biological significance. Birkhauser Verlag, Basel, Switzerland.
45. Sambrook, J., E. F. Fritsch, and T. Maniatis. Molecular cloning: a laboratory manual 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
46. Silke, J., K. I. Rother, O. Georgiev, W. Schaffner, and K. Matsuo. 1995. Complex demethylation patterns at Sp1 binding sites in F9 embryonal carcinoma cells. FEBS Lett. 370:170-174.
47. Stewart, C. L., H. Stuhlmann, D. Jahner, and R. Jaenisch. 1982. De novo methylation, expression, and infectivity of retroviral genomes into embryonal carcinoma cells. Proc. Natl. Acad. Sci. 79:4098-4102.
48. Stocking, C., R. Kollek, U. Bergholz, and W. Ostertag. 1985. Long terminal repeat sequences impart hematopoietic transformation properties to the myeloproliferative sarcoma virus. Proc. Natl. Acad. Sci. USA 82:5746-5750.
49. Taketo, M., and D. J. Shaffer. 1989. Deletion in a recombinant retrovirus genome associated with its expression in embryonal carcinoma cells. J. Virol. 63:4431-4433.
50. Tsukiyama, T., O. Niwa, and K. Yokoro. 1989. Mechanism of suppression of the long terminal repeat of Moloney leukemia virus in mouse embryonal carcinoma cells. Mol. Cell. Biol. 9:4670-4676.
51. Walters, M. C., S. Fiering, J. Eidemiller, W. Magis, M. Groudine, and D. I. K. Martin. 1995. Enhancers increase the probability but not the level of gene expression. Proc. Natl. Acad. Sci. USA 92:7125-7129.
52. Weiher, H., E. Barklis, W. Ostertag, and R. Jaenisch. 1987. Two distinct sequence elements mediate retroviral gene expression in embryonal carcinoma cells. J. Virol. 61:2742-2746.
53. Wilson, C., H. J. Bellen, and W. J. Gehring. 1990. Position effects on eukaryotic gene expression. Annu. Rev. Cell Biol. 6:679-714.